Andrew Price

Company: Novartis

Job title: Senior Principal Scientist

Seminars:

Panel Discussion: Evaluating the Different Preclinical Tumor Models & Their Applications Across Oncology Therapeutic Development 9:00 am

Assessing the pros and cons of the most commonly implemented models, and sharing strategies to select the most appropriate model for your cancer study Discussing their contexts of use across oncology drug development and how to leverage biomarkers, and apply reverse translation to bridge the translational gap What impact has the FDA announcement to phase…Read more

day: Day 2 AM